BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38077439)

  • 1. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
    Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
    PeerJ; 2023; 11():e16424. PubMed ID: 38077439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
    Chen Y; Ren YL; Li N; Yi XF; Wang HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.
    Prueksaritanond N; Angsathapon S; Insin P
    Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.
    Li J; Wang X; Qu W; Wang J; Jiang SW
    Clin Chim Acta; 2019 Jan; 488():215-220. PubMed ID: 30414437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
    Huang GQ; Xi YY; Zhang CJ; Jiang X
    Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
    Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
    Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P
    Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies.
    Abdalla N; Pazura M; Słomka A; Piórkowski R; Sawicki W; Cendrowski K
    Ginekol Pol; 2016; 87(12):781-786. PubMed ID: 28098927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes.
    Liu X; Zhao F; Hu L; Sun Y
    Onco Targets Ther; 2015; 8():1239-43. PubMed ID: 26060409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.
    Dewan R; Dewan A; Hare S; Bhardwaj M; Mehrotra K
    J Clin Diagn Res; 2017 Jul; 11(7):XC01-XC05. PubMed ID: 28893024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.
    Li Y; Wang ZC; Luo L; Mu CY; Xu J; Feng Q; Li SB; Gu B; Ma P; Lan T
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):604-610. PubMed ID: 32016961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.
    Dong C; Liu P; Li C
    Pak J Med Sci; 2017; 33(4):1013-1017. PubMed ID: 29067084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
    Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
    Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma.
    Wang J; Yu L; Sun Y; Zhang L; Tu M; Cai L; Yin X; Pan X; Wang T; Huang Y
    Cancer Manag Res; 2021; 13():8341-8352. PubMed ID: 34764696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.
    Leung F; Bernardini MQ; Brown MD; Zheng Y; Molina R; Bast RC; Davis G; Serra S; Diamandis EP; Kulasingam V
    Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1333-40. PubMed ID: 27448593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.